Loss of Lung Health from Young Adulthood and Cardiac Phenotypes in Middle Age.

RATIONALE Chronic lung diseases are associated with cardiovascular disease. How these associations evolve from young adulthood forward is unknown. Understanding the preclinical history of these associations could inform prevention strategies for common heart-lung conditions. OBJECTIVES To use the Coronary Artery Risk Development in Young Adults (CARDIA) study to explore the development of heart-lung interactions. METHODS We analyzed cardiac structural and functional measurements determined by echocardiography at Year 25 of CARDIA and measures of pulmonary function over 20 years in 3,000 participants. MEASUREMENTS AND MAIN RESULTS Decline in FVC from peak was associated with larger left ventricular mass (β = 6.05 g per SD of FVC decline; P < 0.0001) and greater cardiac output (β = 0.109 L/min per SD of FVC decline; P = 0.001). Decline in FEV1/FVC ratio was associated with smaller left atrial internal dimension (β = -0.038 cm per SD FEV1/FVC decline; P < 0.0001) and lower cardiac output (β = -0.070 L/min per SD of FEV1/FVC decline; P = 0.03). Decline in FVC was associated with diastolic dysfunction (odds ratio, 3.39; 95% confidence interval, 1.37-8.36; P = 0.006). CONCLUSIONS Patterns of loss of lung health are associated with specific cardiovascular phenotypes in middle age. Decline in FEV1/FVC ratio is associated with underfilling of the left heart and low cardiac output. Decline in FVC with preserved FEV1/FVC ratio is associated with left ventricular hypertrophy and diastolic dysfunction. Cardiopulmonary interactions apparent with common complex heart and lung diseases evolve concurrently from early adulthood forward.

[1]  G. Washko,et al.  Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use. , 2014, Chest.

[2]  Jeroen J. Bax,et al.  Impact of right ventricular dyssynchrony on left ventricular performance in patients with pulmonary hypertension , 2014, The International Journal of Cardiovascular Imaging.

[3]  L. Edwards,et al.  Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality , 2014, Thorax.

[4]  L. Edwards,et al.  Coronary artery calci fi cation is increased in patients with COPD and associated with increased morbidity and mortality , 2014 .

[5]  H. Chung,et al.  Association between metabolic syndrome and rate of lung function decline: a longitudinal analysis. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  Benjamin M. Smith,et al.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. , 2013, Chest.

[7]  Benjamin M. Smith,et al.  Pulmonary Hyperinflation and Left Ventricular Mass: The Multi-Ethnic Study of Atherosclerosis COPD Study , 2013, Circulation.

[8]  D. Bluemke,et al.  Associations Among Lung Function, Arterial Elasticity, and Circulating Endothelial and Inflammation Markers: The Multiethnic Study of Atherosclerosis , 2013, Hypertension.

[9]  D. Mannino,et al.  Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010 , 2012, Respiratory Research.

[10]  D. Mannino,et al.  Restricted spirometry in the Burden of Lung Disease Study. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  D. Jacobs,et al.  Rate of Decline of Forced Vital Capacity Predicts Future Arterial Hypertension: The Coronary Artery Risk Development in Young Adults Study , 2012, Hypertension.

[12]  David R. Williams,et al.  The Coronary Artery Risk Development in Young Adults Study Depressive Symptom Clusters and 5-Year Incidence of Coronary Artery Calcification : , 2012 .

[13]  Sanjiv J. Shah,et al.  Right Heart Structural Changes Are Independently Associated with Exercise Capacity in Non-Severe COPD , 2011, PloS one.

[14]  W. Seeger,et al.  Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice , 2011, Cell.

[15]  P. Shekelle,et al.  Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society , 2011, Annals of Internal Medicine.

[16]  M. Wallander,et al.  Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. , 2010, Respiratory medicine.

[17]  Y. Sangwan,et al.  Cardiac Tamponade Occurring Two Weeks After an MRI Exam , 2010 .

[18]  C. Jenkins,et al.  Cardiovascular events in patients with COPD: TORCH Study results , 2010, Thorax.

[19]  H. Magnussen,et al.  Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. , 2010, Chest.

[20]  Eric A. Hoffman,et al.  Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.

[21]  Edwin J R van Beek,et al.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. , 2009, American journal of respiratory and critical care medicine.

[22]  Robert A Wise,et al.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee , 2007, Thorax.

[23]  Judith K Jones,et al.  Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.

[24]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[26]  D. Mannino,et al.  Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  D. Sin,et al.  The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.

[28]  D. Sin,et al.  Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. , 2005, Proceedings of the American Thoracic Society.

[29]  D. Mannino,et al.  Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.

[30]  V. Peinado,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[31]  W Winkelstein,et al.  Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. , 2000, Chest.

[32]  A. Boussuges,et al.  Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. , 2000, American journal of respiratory and critical care medicine.

[33]  D. Postma,et al.  Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. , 1999, American journal of epidemiology.

[34]  E. Trulock,et al.  Right and left ventricular dysfunction in patients with severe pulmonary disease. , 1998, Chest.

[35]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[36]  Randolph P. Martin,et al.  Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[38]  D. Dockery,et al.  Chronic obstructive pulmonary disease mortality in six U.S. cities. , 1989, The American review of respiratory disease.

[39]  L. Kuller,et al.  The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. , 1989, The American review of respiratory disease.

[40]  D. Reed,et al.  Pulmonary function as a predictor of coronary heart disease. , 1989, American journal of epidemiology.

[41]  S B Hulley,et al.  CARDIA: study design, recruitment, and some characteristics of the examined subjects. , 1988, Journal of clinical epidemiology.